Phaseline

Targets › ADRA1A

ADRA1A (Alpha-1A adrenergic receptor): drug programs, companies and trials

76 programs from 62 companies in 108 trials: 45 Phase 4, 24 Phase 3, 22 Phase 2, 17 Phase 1; Cardiovascular, Other, Neurology; next expected readout Nov 2026.

Alpha-1 adrenergic receptors are G protein-coupled receptors for catecholamines that signal through the G(q) family of G proteins, including G(q) and G(11). Upon activation, they stimulate the phosphatidylinositol-calcium second messenger pathway, leading to calcium release from intracellular stores and activation of protein kinase C. ADRA1A binds the catecholamine ligands norepinephrine and epinephrine. (UniProt, P35348)

Open in Phaseline: the race on ADRA1A, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
University of ChicagoPhenylephrine
Adrenergic receptor alpha-1 agonist
ADRA1A, ADRA1D, ADRA1BPhase 4ShockDec 2026
King's College Hospital NHS TrustCarvedilol
Adrenergic receptor beta antagonist; Adrenergic receptor alpha-1 antagonist
ADRB1, ADRB2, ADRB3, ADRA1A, ADRA1DPhase 4Cirrhosis, LiverDec 2026
Cairo UniversityEphedrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Incidence of Post-spinal HypotensionDec 2026
Mansoura UniversityEphedrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Cesarean DeliveryDec 2026
Mansoura UniversityNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Cesarean DeliveryDec 2026
Mansoura UniversitySilodosin
Alpha-1a adrenergic receptor antagonist
ADRA1APhase 4BPH (Benign Prostatic Hyperplasia)Jan 2027
Sohag UniversityNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Patients Undergoing Orthopedic Hip Surgery Under Spinal AnesthesiaMar 2027
Sohag UniversityPhenylephrine
Adrenergic receptor alpha-1 agonist
ADRA1A, ADRA1D, ADRA1BPhase 4Patients Undergoing Orthopedic Hip Surgery Under Spinal AnesthesiaMar 2027
University of AlbertaMidodrine
Adrenergic receptor alpha-1 agonist
ADRA1A, ADRA1D, ADRA1BPhase 4VasoplegiaMar 2027
ARS PharmaceuticalsEpinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Allergic Reactions; Knee Arthroplasty, Total; Cardiac Arrest, Out-Of-Hospital; Shock Hypovolemic …Apr 2027
Icahn School of Medicine at Mount SinaiEphedrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4LaborMay 2027
Beni-Suef UniversitySilodosin
Alpha-1a adrenergic receptor antagonist
ADRA1APhase 4Acute Urinary RetentionMay 2027
Hospital Sirio-LibanesCarvedilol
Adrenergic receptor beta antagonist; Adrenergic receptor alpha-1 antagonist
ADRB1, ADRB2, ADRB3, ADRA1A, ADRA1DPhase 4CancerMay 2027
James J. Peters Veterans Affairs Medical CenterDroxidopa
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4HypotensionJun 2027
James J. Peters Veterans Affairs Medical CenterMidodrine Hydrochloride
Adrenergic receptor alpha-1 agonist
ADRA1A, ADRA1D, ADRA1BPhase 4HypotensionJun 2027
University of California, DavisNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Hypotension and ShockJun 2027
Seoul National University HospitalPhenoxybenzamine
Adrenergic receptor alpha antagonist
ADRA1A, ADRA2A, ADRA2C, ADRA1D, ADRA1BPhase 4PheochromocytomaAug 2027
Aarhus University HospitalLabetalol
Adrenergic receptor antagonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Intracerebral HaemorrhageSep 2027
University of AlbertaNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4VasoconstrictionDec 2027
University of AlbertaPhenylephrine
Adrenergic receptor alpha-1 agonist
ADRA1A, ADRA1D, ADRA1BPhase 4VasoconstrictionDec 2027
Atlantic Health SystemSilodosin
Alpha-1a adrenergic receptor antagonist
ADRA1APhase 4Multiple SclerosisMar 2028
Post Graduate Institute of Medical Education and Research, ChandigarhCarvedilol
Adrenergic receptor beta antagonist; Adrenergic receptor alpha-1 antagonist
ADRB1, ADRB2, ADRB3, ADRA1A, ADRA1DPhase 4Cirrhotic CardiomyopathyJan 2029
Taipei Veterans General Hospital, TaiwanCarvedilol
Adrenergic receptor beta antagonist; Adrenergic receptor alpha-1 antagonist
ADRB1, ADRB2, ADRB3, ADRA1A, ADRA1DPhase 4Hepatocellular Carcinoma (HCC); CirrhosisOct 2030
University of RochesterCarvedilol
Adrenergic receptor beta antagonist; Adrenergic receptor alpha-1 antagonist
ADRB1, ADRB2, ADRB3, ADRA1A, ADRA1DPhase 4Heart Failure With Reduced Ejection Fraction (HFrEF)Jun 2031
Chinese University of Hong KongCarvedilol
Adrenergic receptor beta antagonist; Adrenergic receptor alpha-1 antagonist
ADRB1, ADRB2, ADRB3, ADRA1A, ADRA1DPhase 4Portal HypertensionJul 2031
Bispebjerg HospitalCarvedilol
Adrenergic receptor beta antagonist; Adrenergic receptor alpha-1 antagonist
ADRB1, ADRB2, ADRB3, ADRA1A, ADRA1DPhase 4Acute Myocardial InfarctionDec 2035
Dalian Municipal Central HospitalEphedrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Hypotension Drug-Induced–
Nebraska Methodist Health SystemLabetalol
Adrenergic receptor antagonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Postpartum Preeclampsia–
Tunis UniversityNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Sepsis, Severe–
Dalian Municipal Central HospitalNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Hypotension Drug-Induced–
Hassan II UniversityNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Cesarean Section Complications–
Dalian Municipal Central HospitalPhenylephrine
Adrenergic receptor alpha-1 agonist
ADRA1A, ADRA1D, ADRA1BPhase 4Hypotension Drug-Induced–
Rawalpindi Medical CollegePhenylephrine
Adrenergic receptor alpha-1 agonist
ADRA1A, ADRA1D, ADRA1BPhase 4Phenylephrine–
Hassan II UniversityPhenylephrine
Adrenergic receptor alpha-1 agonist
ADRA1A, ADRA1D, ADRA1BPhase 4Cesarean Section Complications–
NHS Greater Glasgow and ClydeNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 3SepsisNov 2026
Odense University HospitalNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 3ShockDec 2026
VA Office of Research and DevelopmentPrazosin
Adrenergic receptor alpha-1 antagonist
ADRA1A, ADRA1D, ADRA1BPhase 3Posttraumatic Stress DisorderDec 2026
Bir HospitalTamsulosin Hydrochloride
Adrenergic receptor alpha-1 antagonist
ADRA1A, ADRA1D, ADRA1BPhase 3Ureteral Stent-Related SymptomDec 2026
Penang Hospital, MalaysiaTerazosin
Adrenergic receptor alpha-1 antagonist
ADRA1A, ADRA1D, ADRA1BPhase 3Stent Related SymptomsMay 2027
Jagiellonian UniversityNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 3Blood Pressure ManagementJun 2027
CHU de Quebec-Universite LavalTamsulosin hydrochloride
Adrenergic receptor alpha-1 antagonist
ADRA1A, ADRA1D, ADRA1BPhase 3Urinary RetentionJul 2027
Hospital do CoracaoNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 3Septic ShockAug 2027
Opus GeneticsPhentolamine Ophthalmic Solution 0.75%
Non-selective alpha-1 and alpha-2 adrenergic antagonist
ADRA1A, ADRA1B, ADRA1D, ADRA2APhase 3Vision Loss Night; Insulin ResistanceAug 2027
University Hospital, BordeauxNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 3Stroke, AcuteAug 2027
Loma Linda UniversityLabetalol
Adrenergic receptor antagonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 3Postpartum ComplicationDec 2027
University of MinnesotaQsymia
Phentermine/topiramate extended-release combination; sympathomimetic amine and carbonic an
ADRA1A, HTR2CPhase 3Healthy VolunteersOct 2030
University College, LondonTerazosin
Adrenergic receptor alpha-1 antagonist
ADRA1A, ADRA1D, ADRA1BPhase 3Parkinsons Disease (PD)May 2031
SWOG Cancer Research NetworkCarvedilol
Adrenergic receptor beta antagonist; Adrenergic receptor alpha-1 antagonist
ADRB1, ADRB2, ADRB3, ADRA1A, ADRA1DPhase 3CardiotoxicityJun 2031
Ain Shams UniversityCarvedilol
Adrenergic receptor beta antagonist; Adrenergic receptor alpha-1 antagonist
ADRB1, ADRB2, ADRB3, ADRA1A, ADRA1DPhase 3Cardiotoxicity–
University of Turin, ItalyNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 3Critical Illness–
Cairo UniversityOraVerse (phentolamine mesylate)
Alpha-adrenergic antagonist and vasodilator that reverses local anesthetic effects by bloc
ADRA1A, ADRA1BPhase 3Soft Tissue Injuries–
Santen SASOxymetazoline (STN1013800)
Adrenergic receptor alpha agonist
ADRA1A, ADRA2A, ADRA2C, ADRA1D, ADRA1BPhase 3Acquired Blepharophimosis; Sleep Apnea; Perioperative Respiratory Adverse Events; Nasal Obstruction–
Brown UniversityDoxazosin
Adrenergic receptor alpha-1 antagonist
ADRA1A, ADRA1D, ADRA1BPhase 2Alcohol Use Disorder (AUD)Dec 2026
University of Wisconsin, MadisonPrazosin
Adrenergic receptor alpha-1 antagonist
ADRA1A, ADRA1D, ADRA1BPhase 2Magnetic Resonance ImagingMay 2027
University of AarhusNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 2HypotensionDec 2027
University of AarhusPhenylephrine
Adrenergic receptor alpha-1 agonist
ADRA1A, ADRA1D, ADRA1BPhase 2HypotensionDec 2027
Giuseppe Cullaro, MDDroxidopa
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 2Acute Kidney InjuryDec 2027
Ottawa Heart Institute Research CorporationMidodrine
Adrenergic receptor alpha-1 agonist
ADRA1A, ADRA1D, ADRA1BPhase 2Heart Failure With Reduced Ejection FractionJun 2028
Sherief Abd-ElsalamCarvedilol
Adrenergic receptor beta antagonist; Adrenergic receptor alpha-1 antagonist
ADRB1, ADRB2, ADRB3, ADRA1A, ADRA1DPhase 2Esophageal VaricesDec 2030
Michele Tagliati, MDCarvedilol
Adrenergic receptor beta antagonist; Adrenergic receptor alpha-1 antagonist
ADRB1, ADRB2, ADRB3, ADRA1A, ADRA1DPhase 2REM Sleep Behavior Disorder–
Cedars-Sinai Medical CenterCarvedilol
Adrenergic receptor beta antagonist; Adrenergic receptor alpha-1 antagonist
ADRB1, ADRB2, ADRB3, ADRA1A, ADRA1DPhase 2REM Sleep Behavior Disorder–
Cedars-Sinai Medical CenterTerazosin
Adrenergic receptor alpha-1 antagonist
ADRA1A, ADRA1D, ADRA1BPhase 2REM Sleep Behavior Disorder; Symptomatic Parkinson Disease–
Shaheed Mohtarma Benazir Bhutto Institue of TraumaXylometazoline nasal drops 0.1%
Alpha-1 and alpha-2 adrenergic agonist for vasoconstriction
ADRA1A, ADRA1B, ADRA2APhase 2Nasal Bleeding–
Kingston Health Sciences Centrenorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 2Shock–
Kingston Health Sciences Centrephenylephrine
Adrenergic receptor alpha-1 agonist
ADRA1A, ADRA1D, ADRA1BPhase 2Shock–
Geriatric Hospital of Nanjing Medical UniversityNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 1UrolithiasisDec 2026
University of Alabama at BirminghamLabetalol
Adrenergic receptor antagonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 1Hypertension in PregnancyDec 2026
Applied BiologyDA-020
Topical alpha-1 adrenergic agonist
ADRA1APhase 1Chemotherapy Induced AlopeciaFeb 2027
University of ManitobaPhenylephrine
Adrenergic receptor alpha-1 agonist
ADRA1A, ADRA1D, ADRA1BPhase 1Blood Loss, SurgicalJun 2028
Stephen G. KalerDroxidopa
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 1Menkes DiseaseJun 2030
Brigham and Women's HospitalNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 1Hypertension–
Inder Paul Singh, M.D.Omidria
Intracameral phenylephrine and ketorolac combination solution
ADRA1APhase 1Cataract–
Montefiore Medical CenterPhenylephrine
Adrenergic receptor alpha-1 agonist
ADRA1A, ADRA1D, ADRA1BPhase 1Mitral Regurgitation–
Berlin-Chemie AG Menarini GroupTamsulosin
Adrenergic receptor alpha-1 antagonist
ADRA1A, ADRA1D, ADRA1BPhase 1Healthy Volunteers; Healthy Adult Males Volunteers; Healthy Volunteer Male Subjects; Nephrolithiasis …–
University of IowaTerazosin
Adrenergic receptor alpha-1 antagonist
ADRA1A, ADRA1D, ADRA1BPhase 1Healthy–
Mansoura Universitycarvedilol
Adrenergic receptor beta antagonist; Adrenergic receptor alpha-1 antagonist
ADRB1, ADRB2, ADRB3, ADRA1A, ADRA1DPhase 1TBI Traumatic Brain Injury–

Conditions

Shock (5) Hypotension (4) REM Sleep Behavior Disorder (3) Hypotension Drug-Induced (3) Cesarean Delivery (2) Healthy Volunteers (2) BPH (Benign Prostatic Hyperplasia) (2) Acute Urinary Retention (2) Stent Related Symptoms (2) Urinary Retention (2) Cardiotoxicity (2) Vasoconstriction (2)

Modalities

small molecule (72), protein or peptide (1)

Companies

Mansoura University (4) University of Alberta (3) Dalian Municipal Central Hospital (3) Cedars-Sinai Medical Center (2) James J. Peters Veterans Affairs Medical Center (2) Cairo University (2) Sohag University (2) University of Aarhus (2) Hassan II University (2) Kingston Health Sciences Centre (2) Nebraska Methodist Health System (1) University College, London (1) Applied Biology (1) Seoul National University Hospital (1) Bir Hospital (1) Icahn School of Medicine at Mount Sinai (1) Hospital do Coracao (1) Inder Paul Singh, M.D. (1) Tunis University (1) Santen SAS (1)

Related targets

ADRB1 (42) ADRB2 (42) ADRA1D (39) ADRA2A (33) ADRA2C (31) ADRA1B (28) ADRB3 (13) HTR2C (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.